Antimicrobial urinary catheters: A systematic review

Expert Review of Medical Devices

Volumn 5, Issue 4, 2008, Pages 495-506

  Drekonja, Dimitri M ^a,b   Kuskowski, Michael A ^a   Wilt, Timothy J ^a,b   Johnson, James R ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Antimicrobial coated catheter; Bacteriuria; Catheter associated urinary tract infection; Foley catheter; Nosocomial infection

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CORTICOSTEROID; NITROFURAL; SILICONE; SILVER; BIOMATERIAL; URINARY TRACT ANTIINFECTIVE AGENT;

BACTERIURIA; BURNING SENSATION; CANDIDA; CATHETER INFECTION; CATHETERIZATION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; ENTEROBACTER; EVIDENCE BASED PRACTICE; FUNGEMIA; HEMATURIA; HOSPITAL INFECTION; HUMAN; HYDROGEL; INFECTION CONTROL; MATERIAL COATING; NONHUMAN; OUTCOME ASSESSMENT; PAIN; PSEUDOMONAS AERUGINOSA; REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW; TREATMENT DURATION; URINARY CATHETER; URINARY TRACT INFECTION; BLADDER CATHETERIZATION; EQUIPMENT DESIGN; EVIDENCE BASED MEDICINE; INDWELLING CATHETER; INSTRUMENTATION; TREATMENT OUTCOME;

ANTI-INFECTIVE AGENTS, URINARY; CATHETERS, INDWELLING; COATED MATERIALS, BIOCOMPATIBLE; EQUIPMENT DESIGN; EVIDENCE-BASED MEDICINE; HUMANS; TREATMENT OUTCOME; URINARY CATHETERIZATION; URINARY TRACT INFECTIONS;

EID: 58149112373     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/17434440.5.4.495     Document Type: Review

References (30)

1. Warren JW. Catheter-associated urinary tract infections. Int. J. Antimicrob. Agents 17(4), 299-303(2001).
2. Maki DG, Tambyah PA. Engineering out the risk for infection with urinary catheters. Emerg. Inject. Dis. 7(2), 342-347 (2001).
3. Klevens RM, Edwards JR, Richards CL Jr et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 122(2), 160-166 (2007).
4. Saint S, Veenstra DL, Lipsky BA. The clinical and economic consequences of nosocomial central venous catheter-felated infection: are antimicrobial catheters useful? Infect. Control Hosp. Epidemiol. 21(6), 375-380 (2000).
5. Tambyah PA, Knasinski V, Maki DG. The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. Infect. Control Hasp. Epidemiol. 23(1), 27-31 (2002).
6. Rosenthal, MB. Nonpayment for performance? Medicare's new reimbursement rule. N. Engl. J. Med. 357(16), 1573-1575 (2007).
7. Johnson JR, Kuskowski M, Wilt TJ. Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Ann. Intern. Med. 144(2), 116-126 (2006).
8. Stensballe J, Tvede M, Looms D et al. Infection risk with nitrofurazone-impregnated urinary catheters in trauma patients: a randomized trial. Ann. Intern. Med. 147(5), 285-293 (2007).
9. Verleyen P, De Ridder D, Van Poppel H, Baert L. Clinical application of the Bardex IC Foley catheter. Eur. Urol. 36, 240-246 (1999).
10. Liedberg H, Lundeberg T. Prospective study of incidence of urinary tract infection in patients catheterized with Bard hydrogel and silver-coated catheters or Bard hydrogel-coated catheters. J. Urol. 149, 405A (1993) (Abstract).
11. Thibon P, Le Coutour X, Leroyer R, Fabry J. Randomized multi-centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital-acquired urinary tract infections. J. Hosp. Infect. 45, 117-124 (2000).
12. Liedberg H, Lundeberg T, Ekman P. Refinements in the coating of urethral catheters reduces the incidence of catheter-associated bacteriuria. Eur. Urol. 17, 236-240 (1990).
13. Liedberg H, Landeberg T. Silver alloy coated catheters reduce catheter-associated bacteriuria. Br. J. Urol. 65, 379-381 (1990).
14. Lee S, Kim S, Cho Y et al. A comparative multicentre study on the incidence of catheter-associated urinary tract infection between nitrofurazone-coated and silicone catheters. Int. J. Antimicrob. Agents 24(Suppl.), S65-S69 (2004).
15. Karchmer T, Giannetta E, Carlene C, Strain B, Farr B. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch. Intern. Med. 160, 3294-3298 (2000).
16. Al-Habdan I, Sadlat-Ali M, Corea JR, Al-Othman A, Kamal BA, Shriyan DS. Assessment of nosocomial urinary tract infections in orthopedic patients: a prospective and comparative study using two different catheters. Int. Surg. 88, 152-154 (2003).
17. Lundeberg T. Prevention of catheter-associated urinary-tract infections by use of silver-impregnated catheters. Lancet 2(8514), 1031 (1986).
18. Maki DG, Knasinski V, Tambyah PA. A prospective investigator-blinded trial of a novel nitrofurazone-impregnated urinary catheter. Infect. Control Hosp. Epidemiol. 18, 50 (1997) (Abstract).
19. Maki DG, Knasinski V, Halvorson KT, Tambyah PA. A novel silver-hydrogel urinary catheter reduces catheter-associated urinary tract infections. A prospective, randomized, double-blind trial. Infect. Control Hosp. Epidemiol. 19, 682 (1998) (Abstract).
20. Saint S, Elmore JG, Sullivan SD, Emerson SS, Koepsell TD. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis. Am. J. Med. 105(3), 236-241 (1998).
21. Bryan CS, Reynolds KL. Hospital-acquired bacteremic urinary tract infection: epidemiology and outcome. J. Urol. 132(3), 494-498 (1984).
22. Krieger JN, Kaiser DL, Wenzel RP. Urinary tract etiology of bloodstream infections in hospitalized patients. J. Infect. Dis. 148(1), 57-62 (1983).
23. Eykyn SJ. Urinary tract infections in the elderly. Br. J. Urol. 82(Suppl. 1), 79-84 (1998).
24. Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin. Infect. Dis. 40(5), 643-654 (2005).
25. Tambyah PA, Halvorson KT, Maki DG. A prospective study of pathogenesis of catheter-associated urinary tract infections. Mayo Clin. Proc. 74(2), 131-136 (1999).
26. Saint S, Kowalski CP, Kaufman SR et al. Preventing hospital-acquired urinary tract infection in the United States: a national study. Clin. Infect. Dis. 46(2), 243-250 (2008).
27. Huang WC, Wann SR, Lin SL et al. Catheter-associated urinary tract infections in intensive care units can be reduced by prompting physicians to remove unnecessary catheters. Infect. Control Hosp. Epidemiol. 25(11), 974-978 (2004).
28. Topal J, Conklin S, Camp K, Morris V, Balcezak T, Herbert P. Prevention of nosocomial catheter-associated urinary tract infections through computerized feedback to physicians and a nurse-directed protocol. Am. J. Med. Qual. 20(3), 121-126 (2005).
29. Nwadiaro, HC, Nnamonu MI, Ramyil VM, Igun GO. Comparative analysis of urethral catheterization versus suprapubic cystostomy in management of neurogenic bladder in spinal injured patients. Niger. J. Med. 16(4), 318-321 (2007).
30. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273(5), 408-412 (1995).